Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528

Life Sciences

Volumn 65, Issue 6-7, 1999, Pages 627-635

  Shire, David ^a   Calandra, Bernard ^a   Bouaboula, Monsif ^a   Barth, Francis ^a   Rinaldi Carmona, Murielle ^a   Casellas, Pierre ^a   Ferrara, Pascual ^a  

^a SANOFI   (France)

Author keywords

CB1 receptor; CB2 receptor; Inverse agonism; Ligand binding

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; RIMONABANT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG RECEPTOR BINDING; MOLECULAR CLONING; NONHUMAN; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS;

EID: 0033538481     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00285-4     Document Type: Article

References (35)

1. M.R. Hoehe, L. Caenazzo, M.M. Martinez, W.T. Hsieh, W.S. Modi, E.S. Gershon and T.I. Bonner, New Biologist 3 880-885 (1991).
2. L. Stubbs, L. Chittenden, A. Chakrabarti and E. Onaivi, Mammalian Genome 7 165-166 (1996).
3. P.J.M. Valk, S. Hol, Y. Vankan, J.N. Ihle, D. Askew, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, N.J. De Both, B. Löwenberg and R. Delwel, J.Virol. 71 6796-6804 (1997).
4. L.A. Matsuda, Crit.Rev.Neurobiol. 11 143-166 (1997).
5. R.D. Bramblett, A.M. Panu, J.A. Ballesteros and P.H. Reggio, Life Sci. 56 1971-1982 (1995).
6. C.M. Gérard, C. Mollereau, G. Vassart and M. Parmentier, Biochem.J. 279 129-134 (1991).
7. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young and T.I. Bonner, Nature 346 561-564 (1990).
8. A. Chakrabarti, E.S. Onaivi and G. Chaudhuri, DNA Sequence 5 385-388 (1995).
9. M. Pfister-Genskow, G.D. Weesner, H. Hayes, A. Eggen and M.D. Bishop, Mammalian Genome 8 301-302 (1997).
10. G.B. Stefano, B. Salzet and M. Salzet, Brain Res. 753 219-224 (1997).
11. F. Yamaguchi, A.D. Macrae and S. Brenner, Genomics 35 603-605 (1996).
12. D. Shire, B. Calandra, M. Delpech, X. Dumont, M. Kaghad, G. Le Fur, D. Caput and P. Ferrara, J.Biol.Chem. 271 6941-6946 (1996).
13. D. Shire, C. Carillon, M. Kaghad, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, D. Caput and P. Ferrara, J.Biol.Chem. 270 3726-3731 (1995).
14. M. Rinaldi-Carmona, B. Calandra, D. Shire, M. Bouaboula, D. Oustric, F. Barth, P. Casellas, P. Ferrara and G. Le Fur, J.Pharmacol.Exp.Ther. 278 871-878 (1996).
15. S. Munro, K.L. Thomas and M. Abu-Shaar, Nature 365 61-65 (1993).
16. D. Shire, B. Calandra, M. Rinaldi-Carmona, D. Oustric, B. Pessegue, O. Bonnin-Cabanne, G. Le Fur, D. Caput and P. Ferrara, Biochim.Biophys.Acta Gene Struct.Expression 1307 132-136 (1996).
17. F. Barth, Exp.Opin.Ther.Patents 8 301-313 (1998).
18. M.R. Johnson and L.S. Melvin, Cannabinoids as Therapeutic Agents, R. Mechoulam (ed), 121-145, CRC Press, Boca Raton (1986).
19. M. Pacheco, S.R. Childers, R. Arnold, F. Casiano and S.J. Ward, J.Pharmacol.Exp.Ther. 257 170-183 (1991).
20. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.-C. Brelière and G. Le Fur, FEBS Lett. 350 240-244 (1994).
21. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Congy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.C. Brelière and G. Le Fur, J.Pharmacol.Exp.Ther. 284 644-650 (1998).
22. C.D. Strader, T.M. Fong, M.R. Tota, D. Underwood and R.A.F. Dixon, Annu.Rev.Biochem. 63 101-132 (1994).
23. T. Hla and T. Maciag, J.Biol.Chem. 265 9308-9313 (1990).
24. M.I. Masana, R.C. Brown, H. Pu, M.E. Gurney and M.L. Dubocovich, Recept.Channels 3 255-262 (1995).
25. K. Gonda, H. Okamoto, N. Takuwa, Y. Yatomi, H. Okazaki, T. Sakurai, S. Kimura, R. Sillard, K. Harii and Y. Takuwa, Biochem.J. 337 67-75 (1999).
26. M.E. Abood, Q. Tao, S.D. McAllister, D.P. Hurst, J. Norris and P.H. Reggio, 1998 Symposium on the Cannabinoids, Burlington, Vermont, InternationalCannabinoid Research Society 2-2 (1998).
27. Q. Tao and M.E. Abood, J.Pharmacol.Exp.Ther. 285 651-658 (1998).
28. Z.H. Song and T.I. Bonner, Mol.Pharmacol. 49 891-896 (1996).
29. C.N. Chin, J. Lucas-Lenard, V. Abadji and D.A. Kendall, J.Neurochem. 70 366-373 (1998).
30. S.D. McAllister, Q. Tao, P.H. Reggio and M.E. Abood, 1997 Symposium on the Cannabinoids, Stone Mountain, Georgia, International Cannabinoid Research Society (1997).
31. J.Y. Shim, E.R. Collantes, W.J. Welsh, B. Subramaniam, A.C. Howlett, M.A. Eissenstat and S.J. Ward, J.Med.Chem. 41 4521-4532 (1998).
32. M. Bouaboula, S. Perrachon, L. Milligan, X. Canat, M. Rinaldi-Carmona, M. Portier, F. Barth, B. Calandra, F. Pecceu, J. Lupker, J.P. Maffrand, G. Le Fur and P. Casellas, J.Biol.Chem. 272 22330-22339 (1997).
33. M. Portier, M. Rinaldi-Carmona, F. Pecceu, T. Combes, C. Poinot-Chazel, B. Calandra, F. Barth, G. Le Fur and P. Casellas, J.Pharmacol.Exp.Ther. 288 582-589 (1999).
34. R. Leurs, M.J. Smit, A.E. Alewijnse and H. Timmerman, Trends Biochem. Sci. 23 418-422 (1998).
35. D.B. Houston and A.C. Howlett, Cell.Signal. 10 667-674 (1998).